Plus   Neg

Global Blood Therapeutics (GBT) Is Down After Offering Announcement

Global Blood Therapeutics (GBT) announced after the bell Thursday that it intends to offer 3,500,000 shares of its common stock. The stock is now down 2.45 on 41K shares.

Global Blood Therapeutics traded to the downside throughout Thursday's session and closed lower by 3.25 at $56.90. The stock closed testing the lower end of a month and a half long trading range at the highs of the year.

For comments and feedback contact: editorial@rttnews.com

Business News

Follow RTT